Send me a link:

*Text messaging rates may apply.

 Dow Up 0.13% Nasdaq Down 0.10%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
3.44 Down 0.03(0.86%) 4:01PM EDT
Prev Close:3.47
Open:3.47
Bid:3.11 x 100
Ask:6.43 x 3000
1y Target Est:5.95
Beta:1.28
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:3.34 - 3.47
52wk Range:3.16 - 5.60
Volume:165,719
Avg Vol (3m):231,157
Market Cap:318.84M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PLX

Comparison

Symbol% ChgMkt Cap
PLXDown 0.86%318.84M
SHPGDown 0.34%49.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-0.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback